Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27767933

CC(C)(C)OC=O.COc1ccc(-c2ncnc3ccc(-c4ccc(N5CCNCC5)nc4)cc23)cc1OC

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 4/20 0.53
IL2 P60568 3/20 0.53
TLR8 Q9NR97 5/20 0.52
TLR7 Q9NYK1 5/20 0.52
TLR9 Q9NR96 3/20 0.52
PIK3CD O00329 5/20 0.49
PIK3CA P42336 5/20 0.49
PIK3CB P42338 5/20 0.49
PIK3CG P48736 5/20 0.49
MTOR P42345 1/20 0.49
KCNH2 Q12809 1/20 0.46
MELK Q14680 4/20 0.44
USP2 O75604 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27767858 0.97 MAP4K1 (0.51) MAP4K1IL2TLR8TLR7TLR9
SCHEMBL182816 0.91 MAP4K1 (0.61) MAP4K1IL2TLR8TLR7TLR9
SCHEMBL182950 0.89 MAP4K1 (0.60) MAP4K1IL2TLR8TLR7TLR9
SCHEMBL182761 0.81 PIK3CD (0.57) TLR8TLR7PIK3CDPIK3CAPIK3CB
SCHEMBL322733 0.80 PIK3CD (0.50) MAP4K1IL2TLR8TLR7TLR9
SCHEMBL182851 0.79 PIK3CD (0.52) MAP4K1IL2TLR8TLR7TLR9
SCHEMBL183522 0.79 PIK3CD (0.52) MAP4K1IL2TLR8TLR7TLR9
SCHEMBL27767931 0.79 PIK3CD (0.51) MAP4K1IL2TLR8TLR7TLR9
SCHEMBL182904 0.78 PIK3CD (0.57) TLR8TLR7PIK3CDPIK3CAPIK3CB
SCHEMBL28776662 0.78 TLR8 (0.50) MAP4K1IL2TLR8TLR7TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101490016-A 2,4-substituted quinazolines as lipid kinase inhibitors NOVARTIS AG (CH) 2009-07-22 CN claimed
CN-101490016-A 2,4-substituted quinazolines as lipid kinase inhibitors NOVARTIS AG (CH) 2009-07-22 CN disclosed